InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Foster Alan Charles, Directeur Scientifique. Director active across 1 company, notably Otonomy, INC.. Aggregated, 2 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €4k. History available since 14 January 2022. The latest transaction was disclosed on 25 March 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Foster Alan Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,827 shares@ US$2.388100.0% of flowCommon StockSEC:0001209191-22-021546:0
70,000 shares0Common StockSEC:0001209191-22-003740:0
2 of 2 declarations
About Foster Alan Charles
Alan Charles Foster is Chief Scientific Officer at Otonomy, Inc. In this role, he is responsible for the scientific direction and research within the company. His expertise in science and clinical research is essential for the development of new treatments and technologies.
